Trial · NCT02833844
Participant flow16
How many started, completed or left each group, period by period.
1 to 16 of 16
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Double-Blind Period | STARTED | Double-Blind Placebo/Open-Label Evolocumab | 157 | |
| Double-Blind Period | STARTED | Double-Blind Evolocumab/Open-Label Evolocumab | 310 | |
| Double-Blind Period | Randomized and Treated | Double-Blind Placebo/Open-Label Evolocumab | 157 | |
| Double-Blind Period | Randomized and Treated | Double-Blind Evolocumab/Open-Label Evolocumab | 307 | |
| Double-Blind Period | COMPLETED | Double-Blind Placebo/Open-Label Evolocumab | 155 | |
| Double-Blind Period | COMPLETED | Double-Blind Evolocumab/Open-Label Evolocumab | 303 | |
| Double-Blind Period | NOT COMPLETED | Double-Blind Placebo/Open-Label Evolocumab | 2 | |
| Double-Blind Period | NOT COMPLETED | Double-Blind Evolocumab/Open-Label Evolocumab | 7 | |
| Open-Label Period | STARTED | Double-Blind Placebo/Open-Label Evolocumab | 152 | |
| Open-Label Period | STARTED | Double-Blind Evolocumab/Open-Label Evolocumab | 303 | |
| Open-Label Period | Received Open-Label Study Drug | Double-Blind Placebo/Open-Label Evolocumab | 152 | |
| Open-Label Period | Received Open-Label Study Drug | Double-Blind Evolocumab/Open-Label Evolocumab | 299 | |
| Open-Label Period | COMPLETED | Double-Blind Placebo/Open-Label Evolocumab | 150 | |
| Open-Label Period | COMPLETED | Double-Blind Evolocumab/Open-Label Evolocumab | 301 | |
| Open-Label Period | NOT COMPLETED | Double-Blind Placebo/Open-Label Evolocumab | 2 | |
| Open-Label Period | NOT COMPLETED | Double-Blind Evolocumab/Open-Label Evolocumab | 2 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02833844/flow